Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade in Elderly Patients: A Blinded Randomised Study

作者
Matias Vested,Sarah Sofie Wadland,Michelle Icka Christensen,Andreas Creutzburg,Karl Peter Damgård Madsen,Emma Atsuko Tsuchiya,Benedicte Grøngaard Madsen,Marie Louise Rovsing,Christian Sylvest Meyhoff,Kim Lindelof,Arash Afshari,Lars Simon Rasmussen
出处
期刊:Acta Anaesthesiologica Scandinavica [Wiley]
卷期号:70 (1)
标识
DOI:10.1111/aas.70160
摘要

ABSTRACT Introduction Reversal of rocuronium‐induced neuromuscular blockade (NMB) is possible with either neostigmine or sugammadex to prevent residual NMB. In adults, sugammadex provides faster reversal and has fewer side effects compared to neostigmine, even when combined with glycopyrrolate. In elderly patients, rocuronium has a longer onset time and duration of action; however, little is known about the reversal of rocuronium‐induced NMB with either sugammadex or neostigmine and the recovery of muscle function postoperatively. The aim of this study was to determine the time to full recovery of neuromuscular function, defined as Train of Four ratio (TOF) ≥ 0.9 after reversal with either neostigmine 50 μg kg −1 or sugammadex 2 mg kg −1 in elderly patients aged 75 years or above undergoing total intravenous anaesthesia with rocuronium‐induced moderate NMB. We hypothesised that sugammadex 2 mg kg −1 provides a shorter time to TOF ≥ 0.9 compared to neostigmine 50 μg kg −1 . Methods We included 41 patients aged ≥ 75 years with American Society of Anesthesiologists (ASA) physical health classes I–IV scheduled for robotic‐assisted laparoscopic surgery under total intravenous anaesthesia with rocuronium. Patients were randomised to reversal with neostigmine/glycopyrrolate 50/10 μg kg −1 or sugammadex 2 mg kg −1 if the depth of NMB was within the range from TOF count of 2 to a TOF ratio < 0.60. The primary outcome was time to TOF ≥ 0.9, measured from the start of administration of the reversal agent. Secondary outcomes were signs of residual NMB within 90 min after administration of the reversal agent. Results A total of 40 patients were evaluated for the primary outcome. A total of 17 patients received neostigmine/glycopyrrolate and 23 patients received sugammadex. Time to TOF ≥ 0.9 was significantly shorter with sugammadex: 147 s (SD 100) vs. 573 s (SD 501) with a difference of 427 s (95% CI: 205 to 648). No difference was found in the occurrence of clinical signs of residual NMB. Conclusion Time to TOF ≥ 0.9 was shorter after reversal with sugammadex 2 mg kg −1 compared to neostigmine/glycopyrrolate 50/10 μg kg −1 in elderly patients administered rocuronium during total intravenous anaesthesia. For neostigmine a large variation in time to recovery was detected. No significant difference in clinical signs of residual NMB was found. Editorial Comment This trial in an elderly surgical cohort assessed reversal times for rocuronium comparing sugammadex and neostigmine. Sugammadex demonstrated faster and more predictable reversal effects in this cohort. Trial Registration: ClinicalTrials.gov identifier: NCT06228092
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Ava的应助被舒服的士萧采纳,获得10
1秒前
XQYY关注了科研通微信公众号
1秒前
huahuahua发布了新的文献求助10
1秒前
hky完成签到,获得积分10
3秒前
3秒前
文献互助1完成签到,获得积分10
4秒前
4秒前
大模型的应助被cc采纳,获得10
5秒前
YY完成签到 ,获得积分10
5秒前
Kiphank完成签到,获得积分10
6秒前
6秒前
Hello的应助被ziyueqin采纳,获得30
7秒前
7秒前
迷路哑铃完成签到,获得积分10
7秒前
赘婿的应助被林林采纳,获得10
8秒前
Maestro_S的应助被魏伯安采纳,获得10
9秒前
9秒前
9秒前
zrn完成签到 ,获得积分10
9秒前
小瞎鱼发布了新的文献求助10
9秒前
9秒前
huahuahua发布了新的文献求助10
9秒前
今后的应助被shaomianmian采纳,获得10
9秒前
10秒前
迷路哑铃发布了新的文献求助10
10秒前
11秒前
suntreenew完成签到,获得积分10
11秒前
12秒前
Livrik发布了新的文献求助10
12秒前
wangshiqiao由于求助违规,被管理员扣积分10
12秒前
12秒前
Luna发布了新的文献求助10
14秒前
温柔的墨镜完成签到,获得积分10
14秒前
wjxhhkm666完成签到 ,获得积分10
14秒前
西梅发布了新的文献求助10
15秒前
羊布吃稻完成签到,获得积分10
15秒前
tf123发布了新的文献求助10
15秒前
15秒前
科研mrxu完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190810
求助须知:如何正确求助?哪些是违规求助? 9577891
关于积分的说明 21855344
捐赠科研通 7789951
什么是DOI,文献DOI怎么找? 3436475
关于科研通互助平台的介绍 2560308
邀请新用户注册赠送积分活动 2483195